Image For Activity Cover
New Approaches to Assessment and Management of Tricuspid Regurgitation Prior to Intervention: State-of-the-Art Review (JACC Cardiovascular Interventions April 2024)

Severe tricuspid regurgitation (TR) is a progressive condition associated with substantial morbidity, poor quality of life, and increased mortality. Patients with TR commonly have coexisting conditions including congestive heart failure, pulmonary hypertension, chronic lung disease, atrial fibrillation, and cardiovascular implantable electronic devices, which can increase the complexity of medical and surgical TR management.


JACC: Cardiovascular Interventions Editor-in-Chief
David J. Moliterno, MD, FACC

JACC: Cardiovascular Interventions CME/MOC Editor
Michael C. McDaniel, MD

Mackram F. Eleid, MD

Important Dates

Date of Release: April 8, 2024
Term of Approval/Date of CME/MOC Expiration: April 7, 2025

Availability: On-Demand
Expires on Apr 13, 2025
Cost: FREE
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
Android App Download IOS App Download Powered By